News for Professional Diversity Network, Inc. (IPDN)

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a notable transaction by acquiring 1,334,182 shares of Professional Diversity Network

CHICAGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Professional Diversity Network, Inc. ( IPDN) (”œPDN” or the ”œCompany”), a developer and operator of online a

CHICAGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- TalentAlly LLC, a subsidiary company of Professional Diversity Network, Inc. ( IPDN), and a leading diversity recru

Professional Diversity Network, Inc. Announces Financial Results for the Quarter Ended June 30, 2024

Shares of SAP SE SAP rose sharply in today's pre-market trading after the company reported second-quarter financial results. SAP reported quarterly earnings of...

Katherine Lauderdale Appointed to Professional Diversity Network, Inc.'s Board of Directors

Professional Diversity Network appoints new director

Loading... Loading... Shares of Kaival Brands Innovations Group, Inc. KAVL fell sharply during Friday's session after the company announced pricing of $6.0 mil...

Loading... Loading... Shares of Sarepta Therapeutics, Inc. SRPT rose sharply in today's pre-market trading after the company announced expanded US FDA approval...

CHICAGO, June 12, 2024 (GLOBE NEWSWIRE) -- Professional Diversity Network, Inc. (NASDAQ: IPDN) (“PDN” or the “Company”), a developer and operator of...

Loading... Loading... Shares of Science Applications International Corporation SAIC declined 11% to $119.91 following first-quarter results. SAIC reported a 9...

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.

Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults with desmoid tumors. SpringWorks Therapeutics shares rose 14.4% to $23.77 in pre-market trading

The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.00 A.M. ET)..

The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.00 A.M. ET)..

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.29%

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Read Analysts’ New Coverage for May 29th (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS) at ETF Daily News